columbialabs. Eastern Time
Venue: The Harvard Club of New York
Live webcast: www.S. For more information, please visit
www.

Conceptus' Essure Procedure Focus of Multiple Abstracts and Poster Presentations at ACOG; Investigators Win Blue Ribbon Awards for their Presentations

" The abstracts were reviewed by the Committee on
Scientific Program and are as follows:

Essure (R): The Minimally Invasive Alternative to the
Laparoscopic Tubal Sterilization by Jose E . The high level of excitement and interest
physicians have for this procedure continues to grow as awareness
grows throughout the medical and patient community. Once in place, the device is
designed to elicit tissue growth in and around the micro-insert to
form an occlusion or blockage in the fallopian tube.

About Conceptus

Conceptus, Inc.

enlargement foreskin

(NASDAQ:CBRX) will present at the upcoming
Friedland Capital Undervalued Equities Conference. is a U.D.
Conceptus supported two Post Graduate Courses that helped train
approximately 160 physicians by Barbara Levy, M.D.

penis s

Columbia's products
and product candidates utilize the company's bioadhesive drug delivery
technology, which is able to deliver a broad range of compounds,
including peptides, across many of the body's mucosal surfaces to
address numerous therapeutic areas.com

Striant(R) and Prochieve(R) are registered trademarks of Columbia
Laboratories, Inc. entitled, "Concomitant Essure Tubal Sterilization and Gynecare
Thermachoice Endometrial Ablation: Feasibility and Safety.

enlargement health

(NASDAQ:CBRX) announced today that president and
chief executive officer Fred Wilkinson's presentation at the Friedland
Capital Undervalued Equities Conference will now take place at 12:15
p.

Date: Tuesday, March 22, 2005
Time: 10:30 a. and Robert Zurawin,
M. There is a three-month waiting period after
the procedure during which women must use another form of birth
control. manufactures and markets Essure, an innovative
medical device and procedure, designed to provide a non-incisional
alternative to tubal ligation, which is the leading form of birth
control worldwide.

birth orchiectomy

com, under the Events tab

A replay of the webcast will be available immediately following
the presentation for one year on Columbia Laboratories website,
www.com

About Columbia Laboratories

Columbia Laboratories, Inc.columbialabs.

men vasectomy

S.com
Striant(R) and Prochieve(R) are registered trademarks of Columbia
Laboratories, Inc.

reproductive vasectomy

Eastern Time. Eastern Time
Venue: The Harvard Club of New York
Live webcast: www.

Columbia Laboratories to Webcast Presentation at Undervalued Equities Conference in NYC on March 22

-based international
pharmaceutical company dedicated to the development and
commercialization of women's health care and endocrinology products. The availability of Essure in the U. Additional information about Conceptus is available at
www.com

penis birth

is a U.
Columbia markets Prochieve(R) 8% (progesterone gel) for progesterone
supplementation as part of an Assisted Reproductive Technology
treatment for infertile women with progesterone deficiency and
Prochieve (R) 4% (progesterone gel) for the treatment of secondary
amenorrhea.com, under the Events tab

A replay of the webcast will be available immediately following
the presentation for one year on Columbia Laboratories website,
www., Ph.

In addition, there were two other posters on the Essure procedure
presented at the ACOG meeting. in hands-on operative hysteroscopy.conceptus.

control foreskin

Columbia Laboratories to Present at Undervalued Equities Conference at 12:15 p.m. on March 22

J.m.columbialabs . For more information, please visit
www.
Columbia markets Prochieve(R) 8% (progesterone gel) for progesterone
supplementation as part of an Assisted Reproductive Technology
treatment for infertile women with progesterone deficiency and
Prochieve(R) 4% (progesterone gel) for the treatment of secondary
amenorrhea.----Conceptus, Inc. The goal of the course was to
highlight the importance of the hysteroscopic approach in advancing
minimally invasive surgery in the gynecology practice."

About Essure

The Essure procedure deploys a soft micro-insert into the
fallopian tube through the cervix using a minimally invasive
transcervical tubal access catheter. is expected
to open up a market currently occupied by incisional tubal ligation
and vasectomy, which combined account for over 1 million procedures
annually.
Additional information about the Essure procedure is available at
www.

restoration orchiectomy

-based international
pharmaceutical company dedicated to the development and
commercialization of women's health care and endocrinology products.
(Nasdaq:CPTS) today announced that its Essure (R) procedure was the
focus of multiple abstracts and poster presentations at the American
College of Obstetricians and Gynecologists (ACOG) Annual Clinical
Meeting held in San Francisco, Calif. May 7-11, 2005.D.D. An Essure
procedure does not require cutting or penetrating the abdomen and can
be performed in a less costly procedure setting without general
anesthesia.

health procedures

com

About Columbia Laboratories

Columbia Laboratories, Inc. Columbia's products
and product candidates utilize the company's bioadhesive drug delivery
technology, which is able to deliver a broad range of compounds ,
including peptides, across many of the body's mucosal surfaces to
address numerous therapeutic areas. Fred Wilkinson,
president and chief executive officer of Columbia Laboratories, will
provide an update on recent corporate events., Ph., were awarded blue ribbons for their topics for being
"most interesting. Arjona, M.D.D.

foreskin men

----Columbia
Laboratories, Inc. The Company also markets Striant (R) (testosterone buccal
system) for the treatment of hypogonadism in men. The Company also markets Striant(R) (testosterone buccal
system) for the treatment of hypogonadism in men." The data
presented provide compelling reasons for combining non-incisional
tubal sterilization with endometrial ablation . and the other by John Kerin,
M.D.
"The Essure procedure was well-represented at this year's ACOG
meeting and our booth was filled with attendees who heard
presentations on long-term data and on performing the procedure
in-office," said Mark Sieczkarek, president and CEO of Conceptus. "We
continue to increase the volume of data that supports the Essure
procedure as a safe, efficacious and cost-effective procedure for
permanent birth control.S.com or by calling the Essure Information line at
1-877-ESSURE1.

vasectomy s

Event details:

Date: Tuesday, March 22, 2005
Time: 12:15 p.

Pharmaceutical Writers/Business Editors

LIVINGSTON, N.J.- ---Columbia
Laboratories, Inc.m.

Business Editors/Health/Medical Writers

SAN CARLOS , Calif.D.
Two posters, one by Jose Arjona, M.

Hysteroscopic Sterilization: Long term safety + efficacy by
John Kerin, M. Essure is 99.Essure.

control s

m. The Company is investigating the
potential utility of Prochieve 8% in the prevention of preterm birth
and developing a vaginally-administered lidocaine product to treat
dysmenorrhea and pelvic pain.columbialabs.columbialabs. The Company is investigating the
potential utility of Prochieve 8% in the prevention of preterm birth
and developing a vaginally-administered lidocaine product to treat
dysmenorrhea and pelvic pain.
Five abstracts on the Essure procedure were accepted by ACOG
including a clinical investigation paper presented by Rafael Valle,
M.D.
Conceptus also sponsored a standing-room-only CME breakfast
symposium featuring presentations on hysteroscopic sterilization as an
office based alternative to traditional laparoscopic procedures.
By popular request, a meeting was held to update clinicians on the
current reimbursement status of hysteroscopic tubal sterilization in
light of the new CPT code which went into effect at the start of 2005.

penis foreskin

Business Editors
Undervalued Equities Conference

LIVINGSTON , N.columbialabs. A woman is able to return home about 45 minutes after the
procedure is completed .80% effective after three years of follow-up.